Kidney transplant rejection rates and renal graft outcomes have dramatically improved over the past 15 years due to the use of antibody induction therapy and calcineurin inhibitors (CNIs). Unfortunately, the potent immunosuppression induced by these drugs increases the risk of malignancies, infections and nephrotoxicity. While current clinical protocols try to reduce CNI exposure, little is […]
Personalized Immunosuppression Benefits Low-Risk Kidney Transplants








